Search Keyword:


Search option:


IID00850
UniprotQ8IX03
ProteinProtein KIBRA
GeneWWC1
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
1113
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 638-785 Monomer :
 Evidence X-RAY 2z0u A Reference
       Region 2z0u A 638-657 disorder
       Region 2z0u A 658-785 order
 Evidence X-RAY 2z0u B Reference
       Region 2z0u B 638-657 disorder
       Region 2z0u B 658-785 order
Seq 658-785 Homo dimer :
 Evidence X-RAY 6fb4 A Reference
       Region 6fb4 A 658-785 order
 Evidence X-RAY 6fb4 B Reference
       Region 6fb4 B 658-785 order
 Evidence X-RAY 6fd0 A Reference
       Region 6fd0 A 658-785 order
 Evidence X-RAY 6fd0 B Reference
       Region 6fd0 B 658-785 order
 Evidence X-RAY 6fjc A Reference
       Region 6fjc A 658-785 order
 Evidence X-RAY 6fjc B Reference
       Region 6fjc B 658-785 order
 Evidence X-RAY 6fjd A Reference
       Region 6fjd A 658-785 order
 Evidence X-RAY 6fjd B Reference
       Region 6fjd B 658-752 order
       Region 6fjd B 753-755 disorder
       Region 6fjd B 756-785 order
Seqphosphorylation
    975-975 Phosphoserine; by PKC/PRKCZ
    141-141 Phosphoserine
    535-535 Phosphoserine
    542-542 Phosphoserine; by CDK1
    899-899 Phosphoserine
    912-912 Phosphothreonine
    927-927 Phosphoserine
    929-929 Phosphothreonine
    931-931 Phosphoserine; by CDK1
    947-947 Phosphoserine
    978-978 Phosphoserine; by PKC/PRKCZ
 
Prediction
NeProc
Disorder 1-3,95-99,135-156,249-273,329-337,437-482,489-657,788-989,1051-1069,1077-1081,1110-1113
Order 4-94,100-134,157-248,274-328,338-436,483-488,658-787,990-1050,1070-1076,1082-1109
ProS 1-3,135-140,149-156,249-254,329-337,463-482,559-581,611-638,646-652,829-856,862-878,887-910,916-930,937-947,956-972,1051-1069,1077-1081,1110-1113
AlphaFold
Disorder 1-5,42-42,44-54,138-155,205-209,248-296,327-338,356-364,391-393,395-395,428-658,787-813,825-825,828-988,1025-1060,1078-1096,1098-1113
Order 6-41,43-43,55-137,156-204,210-247,297-326,339-355,365-390,394-394,396-427,659-786,814-824,826-827,989-1024,1061-1077,1097-1097
Pfam Hmmer
PF00397 8-37 1.8e-12
PF00397 55-84 3.7e-08
SEG 139-153 ,255-270 ,341-353 ,419-465 ,533-550 ,643-656 ,676-694 ,845-868 ,1034-1050
Function
Function in SwissProt
Negative regulator of the Hippo signaling pathway, also known as the Salvador-Warts-Hippo (SWH) pathway (PubMed:24682284). Enhances phosphorylation of LATS1 and YAP1 and negatively regulates cell proliferation and organ growth due to a suppression of the transcriptional activity of YAP1, the major effector of the Hippo pathway (PubMed:24682284). Along with NF2 can synergistically induce the phosphorylation of LATS1 and LATS2 and function in the regulation of Hippo signaling pathway (PubMed:20159598). Acts as a transcriptional coactivator of ESR1 which plays an essential role in DYNLL1-mediated ESR1 transactivation (PubMed:16684779). Regulates collagen-stimulated activation of the ERK/MAPK cascade (PubMed:18190796). Modulates directional migration of podocytes (PubMed:18596123). Plays a role in cognition and memory performance (PubMed:18672031). Plays an important role in regulating AMPA-selective glutamate receptors (AMPARs) trafficking underlying synaptic plasticity and learning (By similarity).
Biological Process
See also
Diagram with PDB data
AMOT/WWC1Crystal Structure of KIBRA and Angiomotin complex